Elkarsin Tablets (L-Carnitine)

Adult dose

Adults: Administer 2-3g of L-carnitine orally in 2-3 divided doses daily. Adjust the dose as appropriate according to age and symptoms.

This medication should not be administered to certain patients. First, patients who are allergic to this medication or have hypersensitivity or a history of allergies to soybean oil, soy, peanuts, etc. should not take it. Also, patients with fat metabolism disorders, such as hyperlipoproteinemia, diabetic dyslipidemia, or pancreatitis, should use this medication cautiously. Taking this medication may cause temporary side effects such as nausea, vomiting, abdominal pain, diarrhea, changes in body odor. Additionally, skin rashes or hives and facial swelling have also been reported. Some patients with impaired renal function may experience muscle weakness, so caution is advised. Patients at risk of fat overload should have their blood lipid levels checked before taking this medication. If it is determined that fat excretion is not adequate, the medication dosage should be adjusted. Also, if using other lipid injectables, the dosage of other lipid medications should be reduced, considering the amount of lipids contained in this medication. Pregnant women or women who may become pregnant should only take this medication when the benefits of treatment are deemed to outweigh the risks, as the safety of this medication has not been fully established. Lactating women should also use this medication cautiously due to the possibility of it passing into breast milk.

• temporary dizziness
• vomiting
• abdominal pain
• diarrhea
• body odor
• rash
• urticaria
• facial swelling
• myasthenia

This medication should be stored in a tightly closed container to avoid exposure to air or moisture. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius.

Appearance

White round film-coated tablets

Package unit

90 tablets (10 tablets/PTPX9)